Very early stage hepatocellular carcinoma (HCC) is defined as a single tumor with the largest diameter of the lesion measuring 2 cm or less according to Barcelona Liver Cancer staging system. Detection of very early stage HCC is clinically important as it confers an excellent prognosis with the 5-year survival rates over 60 to 80% after patients receive curative treatments. While diagnosing HCC at a very early stage is crucial, it is technically challenging and may come with the physical or psychosocial harms related to diagnostic tests. It is further complicated by the fact that patients with very early stage HCC are not prioritized for liver transplant (LT) in the United States organ allocation system. When LT-eligible patients present with an indeterminate lesion measuring between 1 and 2 cm on the multiphasic computed tomography or magnetic resonance imaging, clinicians often observe patients carefully until the lesion grows up to 2 cm so that patients can be eligible to receive a Model for End-Stage Liver Disease (MELD) exception score for HCC in the United States. The European guideline recommends a routine biopsy of such lesion. In conclusion, attempting to detect very early stage HCC is difficult to achieve and controversial. Clinicians should take into account of the risk and the benefit of diagnostic tests, LT candidacy of patients and the local organ allocation system.
Citations
Citations to this article as recorded by
To Biopsy or Not to Biopsy? Re-examining the Role of Tissue Diagnosis in Hepatocellular Carcinoma Kaushal Madan, Ashish Kumar Journal of Clinical and Experimental Hepatology.2026; 16(1): 103209. CrossRef
Phosphopeptidome Profiling of Human Plasma for Hepatocellular Carcinoma Biomarker Discovery Shafaq Saleem, Muhammad Salman Sajid, Rency S. Varghese, Zaki A. Sherif, Alexander Kroemer, Habtom W. Ressom Journal of Proteome Research.2026; 25(2): 1115. CrossRef
Circulating Tumor Cells as Diagnostic and Therapeutic Biomarkers in Hepatocellular Carcinoma: Advancing Precision Oncology Through Liquid Biopsy Mutaz Jamal Al‐khreisat, Munthar Kadhim‐Abosaoda, Namim Abas Ibrahim, Ms Malathi.H, Priya Priyadarshini‐Nayak, V. Sathiya‐Priya, Gurjant Singh, Ashish Singh Chauhan Journal of Gastroenterology and Hepatology.2026; 41(2): 556. CrossRef
Improved Detection of Small (<2 cm) Hepatocellular Carcinoma via Deep Learning-Based Synthetic CT Hepatic Arteriography: A Multi-Center External Validation Study Jung Won Kwak, Sung Bum Cho, Ki Choon Sim, Jeong Woo Kim, In Young Choi, Yongwon Cho Diagnostics.2026; 16(2): 343. CrossRef
Correspondence to letter to the editor 2 on “Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma” Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su Clinical and Molecular Hepatology.2025; 31(1): e101. CrossRef
Cost-effectiveness analysis of artificial intelligence (AI) in earlier detection of liver lesions in cirrhotic patients at risk of hepatocellular carcinoma in Italy L. Maas, C. Contreras-Meca, S. Ghezzo, F. Belmans, A. Corsi, J. Cant, W. Vos, M. Bobowicz, M. Rygusik, D. K. Laski, L. Annemans, M. Hiligsmann, Karim Lekadir, Kaisar Kushibar, Philippe Lambin, Henry Woodruff, Martijn Starmans, Josep Lluis Gelpi, Jordi Ram Journal of Medical Economics.2025; 28(1): 1023. CrossRef
CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma Hima Makala, Julia Sheehan-Klenk, Woonghee Lee, Joon-Yong Chung, Kwamena E. Baidoo, Divya Nambiar, Peter L. Choyke, Freddy E. Escorcia Journal of Nuclear Medicine.2025; 66(9): 1400. CrossRef
Enhanced diagnostic performance for subcentimeter hepatocellular carcinoma using a novel criterion integrating serum AFP levels and gadolinium-based contrast-enhanced MRI features Xuying Chen, Haoran Dai, Jing Liu, Siyuan Ji, Yuyao Xiao, Xinde Zheng, Kai Hou, Chun Yang BMC Medical Imaging.2025;[Epub] CrossRef
Advances in the Diagnosis, Treatment, and Management of Liver Nodules: A Comprehensive Review Chang Gao, Dongyang Chen, Youpeng Chen Portal Hypertension & Cirrhosis.2025; 4(4): 232. CrossRef
Diagnosis and Treatment Response Monitoring of Liver Cancer Using Glypican-3–Targeted Single-Domain Antibody PET Stanley Fayn, Woonghee Lee, Falguni Basuli, Jianfeng Shi, Hima Makala, Joon-Yong Chung, Dan Li, Divya Nambiar, Jesse Buffington, Robert Morhard, Colleen P. Olkowski, Orit Jacobson, Bradford J. Wood, Rolf E. Swenson, Ross W. Cheloha, Mitchell Ho, Peter L. Clinical Cancer Research.2025; 31(24): 5237. CrossRef
Identification of Proteome-Based Immune Subtypes of Early Hepatocellular Carcinoma and Analysis of Potential Metabolic Drivers Lihong Diao, Mengqi He, Binsheng Xu, Lanhui Chen, Ze Wang, Yuting Yang, Simin Xia, Shengwei Hu, Shuzhen Guo, Dong Li Molecular & Cellular Proteomics.2024; 23(1): 100686. CrossRef
Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma Khaled Mahmoud Mohiedeen, Mona Moustafa Tahoon, Christina Samir Sadek Hanna, Mohamed Adel Abdel Aziz Egyptian Liver Journal.2024;[Epub] CrossRef
Methylated circulating tumor DNA in hepatocellular carcinoma: A comprehensive analysis of biomarker potential and clinical implications Qian Zhu, Jiaqi Xie, Wuxuan Mei, Changchun Zeng Cancer Treatment Reviews.2024; 128: 102763. CrossRef
Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma Dattatrya Shetti, Venkata Ramana Mallela, Wenjing Ye, Mahyar Sharif, Filip Ambrozkiewicz, Andriy Trailin, Václav Liška, Kari Hemminki Critical Reviews in Oncology/Hematology.2024; 200: 104391. CrossRef
The roles of cancer stem cell-derived secretory factors in shaping the immunosuppressive tumor microenvironment in hepatocellular carcinoma Gregory Kenneth Muliawan, Terence Kin-Wah Lee Frontiers in Immunology.2024;[Epub] CrossRef
WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver Roxana Șirli, Alina Popescu, Christian Jenssen, Kathleen Möller, Adrian Lim, Yi Dong, Ioan Sporea, Dieter Nürnberg, Marieke Petry, Christoph F. Dietrich Cancers.2024; 16(16): 2908. CrossRef
Focal liver lesions other than hepatocellular carcinoma in cirrhosis: Diagnostic challenges Kathleen Möller, Ehsan Safai Zadeh, Christian Görg, Yi Dong, Xinwu Cui, Adrian Lim, Chiara de Molo, Carla Serra, Ana Martín Algíbez, Analisa Berzigotti, Fabio Piscaglia, Siegbert Faiss, Christoph F. Dietrich Journal of Translational Internal Medicine.2023; 10(4): 308. CrossRef
Advancements in the Diagnosis of Hepatocellular Carcinoma Natalia Salinas Parra, Heather M. Ross, Adnan Khan, Marisa Wu, Risa Goldberg, Lokesh Shah, Sarah Mukhtar, Jacob Beiriger, Alexis Gerber, Dina Halegoua-DeMarzio International Journal of Translational Medicine.2023; 3(1): 51. CrossRef
Tyrosine kinase inhibitors as potential sensitizers of adoptive T cell therapy for hepatocellular carcinoma Linjun Liang, Xiaoyan Wang, Shuying Huang, Yanwei Chen, Peng Zhang, Liang Li, Yong Cui Frontiers in Immunology.2023;[Epub] CrossRef
Stereotactic Body Radiation Therapy With or Without Transarterial Chemoembolization Versus Transarterial Chemoembolization Alone in Early-Stage Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis Mark P. Dumago, Ryan Anthony F. Agas, Carl Jay E. Jainar, Eugene T. Yap, Lester Bryan A. Co, Teresa T. Sy Ortin Journal of Gastrointestinal Cancer.2023; 54(4): 1058. CrossRef
Serum biomarkers and ultrasensitive biosensors for diagnosis of early-stage hepatocellular carcinoma Lorico DS. Lapitan, Mariusz Pietrzak, Marek Krawczyk, Elżbieta Malinowska Sensors and Actuators B: Chemical.2023; 393: 134209. CrossRef
Magnetic Resonance Imaging-Based Surveillance of Hepatocellular Carcinoma: Current Status and Future Perspectives Hyo Jung Park, So Yeon Kim, Young-Suk Lim Current Hepatology Reports.2023; 22(3): 83. CrossRef
Discovery of a haptoglobin glycopeptides biomarker panel for early diagnosis of hepatocellular carcinoma Mahdokht Kohansal-Nodehi, Magdalena Swiatek-de Lange, Konstantin Kroeniger, Vinzent Rolny, Glòria Tabarés, Teerha Piratvisuth, Tawesak Tanwandee, Satawat Thongsawat, Wattana Sukeepaisarnjaroen, Juan Ignacio Esteban, Marta Bes, Bruno Köhler, Henry Lik-Yuen Frontiers in Oncology.2023;[Epub] CrossRef
Infrastructural considerations of implementing gene therapy for hemophilia in the Nordic context Jan Astermark, Fariba Baghaei, Karin Strandberg, Petra Gabric Toplican, Maj Friberg Birkedal, Emma Engman Grahn, Charlotta Hansson, Peter Kampmann, Anna-Elina Lehtinen, Kinga Täckström, Pål Andre Holme, Maria Magnusson Therapeutic Advances in Hematology.2023;[Epub] CrossRef
External Validation of the FSAC Model Using On-Therapy Changes in Noninvasive Fibrosis Markers in Patients with Chronic Hepatitis B: A Multicenter Study Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, In Kyung Min, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2022; 14(3): 711. CrossRef
Long‐term renal safety between patients with chronic hepatitis B receiving tenofovir vs. entecavir therapy: A multicenter study Young Eun Chon, Soo Young Park, Seung Up Kim, Han Pyo Hong, Jae Seung Lee, Hye Won Lee, Mi Na Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2022; 29(4): 289. CrossRef
Diagnostic accuracy of circulating microRNAs for hepatitis C virus-associated hepatocellular carcinoma: a systematic review and meta-analysis Yicheng Huang, Yingsha Chen, Sheng Tu, Jiajie Zhang, Yunqing Qiu, Wei Yu BMC Infectious Diseases.2022;[Epub] CrossRef
Current Landscape and Future Perspectives of Abbreviated MRI for Hepatocellular Carcinoma Surveillance Hyo Jung Park, Nieun Seo, So Yeon Kim Korean Journal of Radiology.2022; 23(6): 598. CrossRef
Applications of molecular barcode sequencing for the detection of low‐frequency variants in circulating tumour DNA from hepatocellular carcinoma Hye Won Lee, Esl Kim, Kyung Joo Cho, Hye Jung Park, Jieun Seo, Hyeonah Lee, Eunha Baek, Jong Rak Choi, Kwang‐Hyub Han, Seung‐Tae Lee, Jun Yong Park Liver International.2022; 42(10): 2317. CrossRef
Spontaneous Regression of Hepatocellular Carcinoma From Autoinfarction and Implications on Liver Transplantation Kevin Singh ACG Case Reports Journal.2022; 9(7): e00825. CrossRef
Association between serum midkine levels and tumor size in Indonesian hepatocellular carcinoma patients: a cross-sectional study Darmadi Darmadi, Riska Habriel Ruslie, Cennikon Pakpahan Romanian Journal of Internal Medicine.2022; 60(4): 229. CrossRef
Protein phosphatases regulate the liver microenvironment in the development of hepatocellular carcinoma Joon-Sup Yoon, Chang-Woo Lee Experimental & Molecular Medicine.2022; 54(11): 1799. CrossRef
Targeted Next-Generation Sequencing of Plasma Cell-Free DNA in Korean Patients with Hepatocellular Carcinoma Hyojin Chae, Pil Soo Sung, Hayoung Choi, Ahlm Kwon, Dain Kang, Yonggoo Kim, Myungshin Kim, Seung Kew Yoon Annals of Laboratory Medicine.2021; 41(2): 198. CrossRef
A comparison of factors associated with the temporal improvement in the overall survival of BCLC stage 0 hepatocellular carcinoma patients Byeong Geun Song, Min Ji Kim, Dong Hyun Sinn, Wonseok Kang, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Digestive and Liver Disease.2021; 53(2): 210. CrossRef
Prognosis of hepatocellular carcinoma patients diagnosed under regular surveillance: potential implications for surveillance goal Joo Hye Song, Myung Ji Goh, Yewan Park, Joo Hyun Oh, Wonseok Kang, Dong Hyun Sinn, Geum-Youn Gwak, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik Scandinavian Journal of Gastroenterology.2021; 56(3): 274. CrossRef
Therapeutic effects of blocking β-catenin against hepatocellular carcinoma-induced activation of inflammation, fibrosis and tumor invasion Hanan M. Hassan, Sherif M H El-Kannishy, Abdullah Alattar, Reem Alshaman, Ahmed M Hamdan, Mohammed M H Al-Gayyar Biomedicine & Pharmacotherapy.2021; 135: 111216. CrossRef
External validation of CAGE‐B and SAGE‐B scores for Asian chronic hepatitis B patients with well‐controlled viremia by antivirals Jung Hyun Ji, Soo Young Park, Won Jeong Son, Hye Jung Shin, Hyein Lee, Hye Won Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Viral Hepatitis.2021; 28(6): 951. CrossRef
Treatment efficacy by hepatic arterial infusion chemotherapy vs. sorafenib after liver-directed concurrent chemoradiotherapy for advanced hepatocellular carcinoma Sojung Han, Hye Jin Choi, Seung-Hoon Beom, Hye Rim Kim, Hyein Lee, Jae Seung Lee, Hye Won Lee, Jun Yong Park, Seung Up Kim, Do Young Kim, Sang Hoon Ahn, Kwang-Hyub Han, Jinsil Seong, Jong Yun Won, Beom Kyung Kim Journal of Cancer Research and Clinical Oncology.2021; 147(10): 3123. CrossRef
The Prognostic Role of On-Treatment Liver Stiffness for Hepatocellular Carcinoma Development in Patients with Chronic Hepatitis B Hye Won Lee, Hyun Woong Lee, Jae Seung Lee, Yun Ho Roh, Hyein Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Journal of Hepatocellular Carcinoma.2021; Volume 8: 467. CrossRef
Impact of tenofovir alafenamide vs. entecavir on hepatocellular carcinoma risk in patients with chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Hepatology International.2021; 15(5): 1083. CrossRef
Metformin and Dichloroacetate Suppress Proliferation of Liver Cancer Cells by Inhibiting mTOR Complex 1 Tae Suk Kim, Minjong Lee, Minji Park, Sae Yun Kim, Min Suk Shim, Chea Yeon Lee, Dae Hee Choi, Yuri Cho International Journal of Molecular Sciences.2021; 22(18): 10027. CrossRef
Effect of tenofovir alafenamide vs. tenofovir disoproxil fumarate on hepatocellular carcinoma risk in chronic hepatitis B Hye Won Lee, Young Youn Cho, Hyein Lee, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim, Soo Young Park Journal of Viral Hepatitis.2021; 28(11): 1570. CrossRef
An Analysis of Individual and Contextual-Level Disparities in Screening, Treatment, and Outcomes for Hepatocellular Carcinoma Joshua P Kronenfeld, Neha Goel Journal of Hepatocellular Carcinoma.2021; Volume 8: 1209. CrossRef
Individualized surveillance of chronic hepatitis B patients according to hepatocellular carcinoma risk based on PAGE-B scores Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim European Journal of Gastroenterology & Hepatology.2021; 33(12): 1564. CrossRef
Novel Liver Stiffness-Based Nomogram for Predicting Hepatocellular Carcinoma Risk in Patients with Chronic Hepatitis B Virus Infection Initiating Antiviral Therapy Jae Seung Lee, Hyun Woong Lee, Tae Seop Lim, Hye Jung Shin, Hye Won Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2021; 13(23): 5892. CrossRef
Hepatocellular carcinoma surveillance, early detection and survival in a privately insured US cohort Vincent L. Chen, Amit G. Singal, Elliot B. Tapper, Neehar D. Parikh Liver International.2020; 40(4): 947. CrossRef
Improved detection of hepatocellular carcinoma by dynamic computed tomography in cirrhotic patients with chronic hepatitis B: A multicenter study Ji Hyun Kim, Seong Hee Kang, Minjong Lee, Hoon Sung Choi, Baek Gyu Jun, Tae Suk Kim, Dae Hee Choi, Ki Tae Suk, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Soon Koo Baik, Dong Joon Kim Journal of Gastroenterology and Hepatology.2020; 35(10): 1795. CrossRef
Prognosis of Early-Stage Hepatocellular Carcinoma: Comparison between Trans-Arterial Chemoembolization and Radiofrequency Ablation Byung-Yoon Yun, Hye Won Lee, In Kyung Min, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2020; 12(9): 2527. CrossRef
Imaging Modalities for Hepatocellular Carcinoma Surveillance: Expanding Horizons beyond Ultrasound Hyo Jung Park, So Yeon Kim Journal of Liver Cancer.2020; 20(2): 99. CrossRef
Factors Associated With Detection and Survival of T1 Hepatocellular Carcinoma in the United States: National Cancer Database Analysis Ju Dong Yang, Michael Luu, Amit G. Singal, Mazen Noureddin, Alexander Kuo, Walid S. Ayoub, Vinay Sundaram, Honore Kotler, Irene K. Kim, Tsuyoshi Todo, Georgios Voidonikolas, Todd V. Brennan, Kambiz Kosari, Andrew S. Klein, Andrew Hendifar, Shelly C. Lu, N Journal of the National Comprehensive Cancer Network.2020; 18(9): 1210. CrossRef
Hepatocellular Carcinoma Risk According to Regimens for Eradication of Hepatitis C Virus; Interferon or Direct Acting Antivirals Hye Won Lee, Dai Hoon Han, Hye Jung Shin, Jae Seung Lee, Seung Up Kim, Jun Yong Park, Do Young Kim, Sang Hoon Ahn, Beom Kyung Kim Cancers.2020; 12(11): 3414. CrossRef
Preclinical efficacy of a novel dual PI3K/mTOR inhibitor, CMG002, alone and in combination with sorafenib in hepatocellular carcinoma Mi Na Kim, Seung Min Lee, Jin Sung Kim, Seong Gyu Hwang Cancer Chemotherapy and Pharmacology.2019; 84(4): 809. CrossRef
First
Prev
